CHL1 and neoplasm: This approach has been successfully used in experimental models targeting ST8SiaII and ST8SiaIV in order to inhibit polysialylation of NCAM (Neural Cell Adhesion Molecule) in rhabdomyosarcoma tumor cells [27].